מארסביה - Mresvia

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	J07BX Other viral vaccines
××¨××× ×¤×¢×× (ATC5)	Â RNA-100-AR02 0.1 MG / 1 ML âJ07BX05
×¦××¨×ª ××ª×	×ª××-×©×¨××¨× - I.M
×¦××¨×ª ××× ××	DISPERSION FOR INJECTION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	MRESVIA is indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by Respiratory Syncytial Virus in adults 60 years of age and older.
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ××× ×¢××× ××¨××¤× Â

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¨×¡××× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	MODERNA BIOTECH S.L., SPAIN
×©× ××¢× ××¨××©××	MEDISON PHARMA LTD
×¨××©×××	×ª××¨×× ×××©×: 3/2025. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	04/01/2026

השינוי האחרון נעשה בֹ־7 בינואר 2026 ב־01:16